price month
outperform result lower sale
keep respect adj ep essenti flat averag reflect slightli
lower oper earn off-set reduc tax rate roll dcf
upgrad target price retain outperform
rate think manag could gener substanti valu put
compani substanti net cash posit work
await major execut contrari tecan report
pleas organ sale growth partner busi
underli declin life scienc sale clearli less
impress light underli order entri growth
see manag guidanc call mid-singl digit fx adj sale
growth well like-for-lik ebitda margin estim
y/i think margin develop reassur given
on-going materi cost-sav effort growth drive product run
cost curv reduc acquisit relat cost
comfort margin progress regard manag
guidanc ebitda margin improv realist
net cash balanc end market cap
substanti debt financ capac give tecan fire power
least estim assum acquisit multipl
ebitda incl synergi tecan could purchas asset gener
least ebitda equal least group ebitda report
given fragment consolid natur life scienc
industri optimist eventu tecan find larger target
catalyst risk result due august
valuat get target price use dcf methodolog
assum sale growth adj ebit margin
averag tecan trade demand price-to-earnings note
ev/ebitda multipl line life scienc peer
valuat metric
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price rate outperform target price analyst christoph gretler
tecan group ag switzerland-bas compani engag
develop product distribut advanc autom
detect solut life scienc laboratori
ramp oem partner project exce expect
averag underli growth midterm touch
price target reach per share
pick dako omni sale orthovis begin
declin mid term price target could reach
price rel chart measur perform swiss market
ind close
spot exchang rate
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
sales/ep tecan report result slightli cse
compani compil consensu main
shortfal life scienc busi sale declin y/i though
manag concern result result present
compani report order entri growth y/i underli
segment partner busi report sale cse
y/i underli cse driven solid consum sale new instrument platform
sale hand life scienc busi sale came cse
y/i organ cse underli sale declin
manag put high comparison base
gross profit came cse translat margin
cse y/i somewhat posit impact non-recur effect
increas attribut posit effect procur cost save
report ebitda came cse correspond margin
cse adjust unexpect non-recur posit effect
ebitda margin line expect division ebit margin
life scienc cse y/i partner busi
ebit margin cse y/i net cash report
board propos pay dividend cse
manag target organ sale growth mid-singl digit cse
report ebitda margin least cse manag
guid capital-expenditure line
adjust forecast follow
figur estim chang
sfr million unless otherwis state
base updat estim tecan share trade forward price-to-earnings
industri averag forward price-to-earnings
averag adjust net cash posit look ev/ebitda
multipl reveal compani trade line relev life scienc
per estimatesprevi estim charl martineau pm univers toronto figur rel valuation- industri peer
get target price tecan use dcf methodolog assum
averag sale growth adj ebit margin averag
sfr million unless otherwis state
us million bionot fishernot life scienc ev salesc ev ebitdac oper expens incl sale depreci tax adj depreci chang work capit capit expenditur chang invest oper net liquid end pension deficit end valu per share ebit cash tax work capit averag cost capit charl martineau pm univers toronto
sfr million unless otherwis state
growth analysi intern growth extern growth local currenc usd euro currenc impact busi profit product line cs profit product charl martineau pm univers toronto
sfr million unless otherwis state
net ep cs adjust fulli good net net oper net gross fix invest fix net acquisit relat gross invest gain profit charl martineau pm univers toronto
compani mention price
christoph gretler certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
